Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial

Background In event‐driven clinical trials, study termination is based on accrual of a target number of primary efficacy events. For noninferiority trials in which superiority is conditionally examined, the ideal cohort in which to track event accrual is unclear. We used data from the ROCKET AF (Riv...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Anthony P. Carnicelli, Anne S. Hellkamp, Kenneth W. Mahaffey, Daniel E. Singer, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Robert M. Califf, Manesh R. Patel
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2021-10-01
Schriftenreihe:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Schlagworte:	anticoagulation atrial fibrillation clinical trial embolic stroke research methodology warfarin
Online-Zugang:	https://www.ahajournals.org/doi/10.1161/JAHA.121.022485
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!